Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component
1 clinical trials · Condition
◉ Watch Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component
| Record | Firm | Date |
|---|---|---|
| Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma (NCT00807495) | Millennium Pharmaceuticals, Inc. | 2009-02-10 |
Track Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component automatically
Every clearance here is in the API, with alerts when new ones post.